Business Description
![Milestone Pharmaceuticals Inc Milestone Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000BM9M.png?14)
Milestone Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA59935V1076
Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.7 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 1.32 | |||||
Debt-to-EBITDA | -1.02 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 8.3 | |||||
3-Year EPS without NRI Growth Rate | 6.5 | |||||
3-Year FCF Growth Rate | 14.4 | |||||
3-Year Book Growth Rate | -52.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 17.22 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.72 | |||||
9-Day RSI | 51.06 | |||||
14-Day RSI | 51.56 | |||||
6-1 Month Momentum % | -12.99 | |||||
12-1 Month Momentum % | -57.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 22.75 | |||||
Quick Ratio | 22.75 | |||||
Cash Ratio | 21.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -82.04 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -4153.4 | |||||
ROE % | -153.42 | |||||
ROA % | -59.05 | |||||
ROIC % | -1239.49 | |||||
ROC (Joel Greenblatt) % | -2233.8 | |||||
ROCE % | -59.81 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 65.65 | |||||
PB Ratio | 2.01 | |||||
Price-to-Tangible-Book | 2.01 | |||||
EV-to-EBIT | -0.82 | |||||
EV-to-EBITDA | -0.82 | |||||
EV-to-Forward-EBITDA | -1.24 | |||||
EV-to-Revenue | 42.4 | |||||
EV-to-Forward-Revenue | 21.78 | |||||
EV-to-FCF | -1.02 | |||||
Price-to-Net-Current-Asset-Value | 2.13 | |||||
Price-to-Net-Cash | 2.4 | |||||
Earnings Yield (Greenblatt) % | -121.95 | |||||
FCF Yield % | -51.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MIST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Milestone Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1 | ||
EPS (TTM) ($) | -1.25 | ||
Beta | 0 | ||
Volatility % | 71.13 | ||
14-Day RSI | 51.56 | ||
14-Day ATR ($) | 0.084406 | ||
20-Day SMA ($) | 1.4559 | ||
12-1 Month Momentum % | -57.99 | ||
52-Week Range ($) | 1.12 - 3.62 | ||
Shares Outstanding (Mil) | 53.27 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Milestone Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Milestone Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Milestone Pharmaceuticals Inc Frequently Asked Questions
What is Milestone Pharmaceuticals Inc(MIST)'s stock price today?
The current price of MIST is $1.51. The 52 week high of MIST is $3.62 and 52 week low is $1.12.
When is next earnings date of Milestone Pharmaceuticals Inc(MIST)?
The next earnings date of Milestone Pharmaceuticals Inc(MIST) is 2024-08-09 Est..
Does Milestone Pharmaceuticals Inc(MIST) pay dividends? If so, how much?
Milestone Pharmaceuticals Inc(MIST) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |